Recent Quotes
View Full List
My Watchlist
WisdomTree Cloud Computing Fund
Edit Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
OmniAb, Inc. - Common Stock
(NQ:
OABI
)
5.110
-0.120 (-2.29%)
Delayed Quote
Updated: 4:00 PM EDT, Oct 30, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about OmniAb, Inc. - Common Stock
< Previous
1
2
3
4
5
Next >
OmniAb (OABI) Q3 2026 Earnings Call Transcript
↗
October 30, 2026
Revenue jumped to $4M as xPloration expands and Lilly partnership unlocks $3B in milestones.
Via
The Motley Fool
Topics
Earnings
OmniAb Q3 Earnings Call Highlights
↗
October 30, 2026
OmniAb (NASDAQ:OABI) reported higher third-quarter revenue and raised its full-year 2026 revenue and year-end cash outlook, citing partner-program milestones, expanding service revenue and early...
Via
MarketBeat
Topics
Earnings
OmniAb Inc. (NASDAQ:OABI) Q3 2026 Revenue Beat and Raised Guidance Offset by Sell-the-News Pressure
↗
October 30, 2026
Via
Chartmill
OmniAb Reports Third Quarter 2026 Financial Results and Business Highlights
October 30, 2026
From
OmniAb, Inc.
Via
Business Wire
OmniAb (NASDAQ:OABI) Passes Minervini Trend Template and High-Growth Momentum Screen
↗
August 22, 2026
Via
Chartmill
OmniAb (NASDAQ:OABI) Beats Q2 Estimates and Raises Full-Year Guidance
↗
August 06, 2026
Via
Chartmill
OmniAb (NASDAQ:OABI) Surges on Q1 Beat and Raised 2026 Guidance
↗
May 07, 2026
Via
Chartmill
OmniAb to Participate in Upcoming Investor Conferences in November
October 26, 2026
From
OmniAb, Inc.
Via
Business Wire
OmniAb Highlights $3B Milestone Pipeline, AI Antibody Platform at Conference
↗
October 25, 2026
OmniAb (NASDAQ:OABI) Chief Financial Officer Kurt Gustafson outlined the company’s antibody-discovery platform, partner pipeline and revenue model during a company presentation, emphasizing a strategy...
Via
MarketBeat
Topics
Artificial Intelligence
OmniAb to Report Third Quarter 2026 Financial Results on October 30
October 14, 2026
From
OmniAb, Inc.
Via
Business Wire
OmniAb Investor Day Spotlights Royalty Pipeline, OmniTides Launch and xPloration Growth
↗
October 07, 2026
OmniAb (NASDAQ:OABI) used its investor and analyst day to outline its strategy for expanding royalty-bearing partnerships, commercializing its xPloration screening platform and entering the...
Via
MarketBeat
OmniAb Highlights Partner Pipeline, xPloration® Plans and Outlook, and Introduces the OmniTides™ Platform at Investor & Analyst Day
October 06, 2026
From
OmniAb, Inc.
Via
Business Wire
OmniAb to Host Investor & Analyst Day on October 6, 2026
September 14, 2026
From
OmniAb, Inc.
Via
Business Wire
OmniAb to Participate in Upcoming Investor Conferences
August 26, 2026
From
OmniAb, Inc.
Via
Business Wire
There are notable gap-ups and gap-downs in today's session.
↗
August 17, 2026
Via
Chartmill
These stocks are moving in today's pre-market session
↗
August 17, 2026
Via
Chartmill
OmniAb Raises 2026 Financial Guidance
August 17, 2026
From
OmniAb, Inc.
Via
Business Wire
OmniAb Announces Global Collaboration and License Agreement for Ion Channel Program with Eli Lilly & Company
August 17, 2026
From
OmniAb, Inc.
Via
Business Wire
OmniAb (OABI) Q2 2026 Earnings Call Transcript
↗
August 14, 2026
Clinical programs advance as OmniAb raises full-year revenue guidance to $32M-$36M.
Via
The Motley Fool
Topics
Earnings
OmniAb Q2 Earnings Call Highlights
↗
August 07, 2026
OmniAb (NASDAQ:OABI) reported higher second-quarter revenue and a narrower net loss as milestone payments from partner programs increased, while the company raised its full-year 2026 revenue and...
Via
MarketBeat
Topics
Earnings
OmniAb Reports Second Quarter 2026 Financial Results and Business Highlights
August 06, 2026
From
OmniAb, Inc.
Via
Business Wire
BioMedNewsBreaks — VERAXA Biotech AG (NASDAQ: VRXA) Advances Bispecific ADC Program Under OmniAb Collaboration
July 27, 2026
Via
Investor Brand Network
OmniAb to Report Second Quarter 2026 Financial Results on August 6
July 16, 2026
From
OmniAb, Inc.
Via
Business Wire
OmniAb Names Amechi Nwachuku Chief Operating Officer
July 13, 2026
From
OmniAb, Inc.
Via
Business Wire
OmniAb (OABI) Q1 2026 Earnings Transcript
↗
May 08, 2026
OmniAb (OABI) Q1 2026 Earnings Transcript
Via
The Motley Fool
OmniAb Q1 Earnings Call Highlights
↗
May 08, 2026
OmniAb (NASDAQ:OABI) reported first-quarter 2026 results that management characterized as a “very strong start to the year,” driven primarily by clinical progress across its partner portfolio and...
Via
MarketBeat
Topics
Earnings
OmniAb Reports First Quarter 2026 Financial Results and Business Highlights
May 07, 2026
From
OmniAb, Inc.
Via
Business Wire
OmniAb to Participate in Three Upcoming Investor Conferences
April 24, 2026
From
OmniAb, Inc.
Via
Business Wire
OmniAb to Report First Quarter 2026 Financial Results on May 7
April 21, 2026
From
OmniAb, Inc.
Via
Business Wire
OmniAb (OABI) Q4 2025 Earnings Call Transcript
↗
March 15, 2026
OmniAb (OABI) Q4 2025 Earnings Call Transcript
Via
The Motley Fool
Topics
Earnings
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.